Literature DB >> 28837877

CTGF secreted by mesenchymal-like hepatocellular carcinoma cells plays a role in the polarization of macrophages in hepatocellular carcinoma progression.

Tian-Tian Wang1, Ji-Hang Yuan1, Jin-Zhao Ma1, Wen-Jun Yang1, Xiao-Ning Liu1, Yu-Peng Yin1, Yan Liu1, Wei Pan1, Shu-Han Sun2.   

Abstract

M2 macrophages play critical roles in the progression of hepatocellular carcinoma (HCC), and they are associated with poor outcomes. TGF-β-induced epithelial-mesenchymal transition (EMT) has been shown to be critically important to cancer cell dissemination in HCC. However, the relationship between stromal-like HCC cells and M2 macrophages formation is not clear. Here, we interrogated the molecular link between mesenchymal-like HCC cells and the formation of M2 macrophages. We demonstrated that mesenchymal-like HCC cells secrete connective tissue growth factor (CTGF) to polarized macrophages. Reciprocally, Chemokine ligand 18 (CCL18) from M2 macrophages promotes HCC progression. Furthermore, CTGF and CCL18 were increased significantly in HCC compared to adjacent normal liver tissues. In summary, our study discovered a positive feedback loop between CTGF and CCL18 in HCC metastasis. Targeting CTGF or CCL18 might provide beneficial effects for the clinical treatment of HCC.
Copyright © 2017. Published by Elsevier Masson SAS.

Entities:  

Keywords:  CCL18; CTGF; Hepatocellular carcinoma; M2 macrophages; TGF-β

Mesh:

Substances:

Year:  2017        PMID: 28837877     DOI: 10.1016/j.biopha.2017.08.004

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  9 in total

1.  M2-polarized macrophages mediate wound healing by regulating connective tissue growth factor via AKT, ERK1/2, and STAT3 signaling pathways.

Authors:  Si-Min Zhang; Chuan-Yuan Wei; Qiang Wang; Lu Wang; Lu Lu; Fa-Zhi Qi
Journal:  Mol Biol Rep       Date:  2021-08-16       Impact factor: 2.316

Review 2.  Connective Tissue Growth Factor in Idiopathic Pulmonary Fibrosis: Breaking the Bridge.

Authors:  Wiwin Is Effendi; Tatsuya Nagano
Journal:  Int J Mol Sci       Date:  2022-05-28       Impact factor: 6.208

3.  The long non-coding RNA CRNDE competed endogenously with miR-205 to promote proliferation and metastasis of melanoma cells by targeting CCL18.

Authors:  Libin Xu; Yu Zhang; Zhenguo Zhao; Zhengju Chen; Zheng Wang; Songfeng Xu; Xinxin Zhang; Ting Liu; Shengji Yu
Journal:  Cell Cycle       Date:  2018-10-09       Impact factor: 4.534

4.  Decoding Immune Heterogeneity of Melanoma and identifying immune-prognostic hub genes.

Authors:  Yu Zhang; Siyu Hao; Yingli Gao; Weina Sun; Yuzhen Li
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

Review 5.  Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy.

Authors:  Konstantinos Arvanitakis; Triantafyllia Koletsa; Ioannis Mitroulis; Georgios Germanidis
Journal:  Cancers (Basel)       Date:  2022-01-04       Impact factor: 6.639

6.  Low MARCO Expression is Associated with Poor Survival in Patients with Hepatocellular Carcinoma Following Liver Transplantation.

Authors:  Qi Zhang; Yuxuan Wei; Yihu Li; Xingyuan Jiao
Journal:  Cancer Manag Res       Date:  2022-06-11       Impact factor: 3.602

Review 7.  From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma.

Authors:  Yaojie Fu; Shanshan Liu; Shan Zeng; Hong Shen
Journal:  J Exp Clin Cancer Res       Date:  2019-09-09

8.  Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt/β-catenin signaling.

Authors:  Xiaohui Tian; Yuanyuan Wu; Yating Yang; Jiaxin Wang; Menglan Niu; Shanjun Gao; Tao Qin; Dengke Bao
Journal:  Mol Oncol       Date:  2019-12-21       Impact factor: 6.603

Review 9.  CCL18 in the Progression of Cancer.

Authors:  Jan Korbecki; Mateusz Olbromski; Piotr Dzięgiel
Journal:  Int J Mol Sci       Date:  2020-10-26       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.